SCHEMBL873097

SCHEMBL873097

C=C/C=C\CC(O)CCC

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2639497 1.00 FFAR1 (0.33) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL873099 1.00 FFAR1 (0.33) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL586079 1.00 FFAR1 (0.33) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL2828890 0.92 FPR2 (0.33) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL2830306 0.92 FPR2 (0.33) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL2864017 0.92 FPR2 (0.33) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL13021370 0.92 FPR2 (0.33) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL15827689 0.92 FPR2 (0.33) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL30853070 0.84 FFAR1 (0.50) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL30005487 0.84 FFAR1 (0.50) FFAR1FFAR4NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302678-A1 ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS PROCTER & GAMBLE (US) 2025-10-02 US claimed
EP-4615941-A2 SUBSTITUTED 1,3-DIOXOLAN-4-ONES AND 1,3-DIOXAN-4-ONES AS FRAGRANCE INGREDIENTS BASF SE (DE) 2025-09-17 EP claimed
US-12350136-B2 Absorbent articles including perfume and cyclodextrins THE PROCTER & GAMBLE COMPANY (US) 2025-07-08 US claimed
US-12338225-B2 2,2,6-trimethyl-4,5-dihydro-3H-oxepine as aroma ingredient BASF SE (DE) 2025-06-24 US claimed
US-20250092331-A1 COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS BASF SE (DE) 2025-03-20 US claimed
EP-4096618-B1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2025-01-29 EP claimed
US-12187978-B2 Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical BASF SE (DE) 2025-01-07 US claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
US-20240240106-A1 1,4-BUTANEDIOL MONO- OR DIESTERS FOR USE AS AROMA CHEMICALS BASF SE (DE) 2024-07-18 US claimed
CN-114174277-B 2, 6-Trimethyl-4, 5-dihydro-3H-oxaheptacyclic as aromatic component 巴斯夫欧洲公司 2024-06-04 CN claimed
EP-3197507-A1 MALODOR REDUCTION COMPOSITIONS The Procter and Gamble Company (US) 2017-08-02 EP claimed
US-20160250115-A1 COMPOSITIONS COMPRISING AN EFFICIENT PERFUME BLOOM PROCTER & GAMBLE (US) 2016-09-01 US claimed
US-9364409-B2 Compositions comprising an efficient perfume bloom THE PROCTER & GAMBLE COMPANY (US) 2016-06-14 US claimed
US-20160089464-A1 MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
WO-2016049389-A1 MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20160030320-A1 COMPOSITIONS COMPRISING AN EFFICIENT PERFUME BLOOM PROCTER & GAMBLE (US) 2016-02-04 US claimed
CN-105188400-A Compositions and methods for preventing, reducing, alleviating, or treating idiopathic vomiting IAMS COMPANY 2015-12-23 CN claimed
CN-103561713-A Compositions comprising an efficient perfume bloom PROCTER & GAMBLE 2014-02-05 CN claimed
US-20120322709-A1 COMPOSITIONS COMPRISING AN EFFICIENT PERFUME BLOOM THE PROCTER & GAMBLE COMPANY 2012-12-20 US claimed
WO-2012162331-A2 COMPOSITIONS COMPRISING AN EFFICIENT PERFUME BLOOM THE PROCTER & GAMBLE COMPANY (US) 2012-11-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12338225-B2 2,2,6-trimethyl-4,5-dihydro-3H-oxepine as aroma ingredient DRD4, HTR5A, HTR4 FFAR1 578/4885FFAR4 222/4885NFKB1 3234/4885
US-20250092331-A1 COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS OXER1, MSMO1, IPO7 FFAR1 1562/4885FFAR4 1122/4885NFKB1 2600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.